Lynwood Capital Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30	Closed	-$613K	–	144
2022 Q4	$613K	Buy	30 +10	+50%	+$204K	0.74%	50
2022 Q3	$400K	Buy	20 +3	+18%	+$60K	0.44%	69
2022 Q2	$347K	Buy	17 +2	+13%	+$40.8K	0.39%	64
2022 Q1	$296K	Buy	+15	New	+$296K	0.32%	71